PTEライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary ():

Stats
本日の出来高	0
平均出来高	0
時価総額	0
EPS	$0 ( 2024-03-25 )
次の収益日	( $0 ) 2024-05-14
Last Dividend	$50.40 ( 2016-01-19 )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

PolarityTE Inc 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

PolarityTE Inc 財務諸表

Annual	2022
収益:	$814 000
総利益:	$198 000 (24.32 %)
EPS:	$1.490

FY	2022
収益:	$814 000
総利益:	$198 000 (24.32 %)
EPS:	$1.490

FY	2021
収益:	$9.40M
総利益:	$5.09M (54.10 %)
EPS:	$-9.50

FY	2020
収益:	$10.13M
総利益:	$5.70M (56.31 %)
EPS:	$-27.75

Financial Reports:

No articles found.

PolarityTE Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

PolarityTE Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$50.33	2016-01-12
Last Dividend	$50.40	2016-01-19
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$100.73	--
Avg. Dividend % Per Year	0.00%	--
Score	2.02	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-04-29)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

2.02

Pay Frequency

Monthly

Yearly Payout

Year	Amount	Yield
2016	$100.73	65.20%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	0.676	1.200	10.00	10.00	[0 - 0.3]
returnOnEquityTTM	0.841	1.500	1.769	2.65	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	4.11	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	3.15	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.94	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.164	-1.500	7.27	-10.00	[0 - 0.6]
interestCoverageTTM	-685.22	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-1.281	2.00	-0.427	-0.854	[0 - 30]
freeCashFlowPerShareTTM	-1.285	2.00	-0.643	-1.285	[0 - 20]
debtEquityRatioTTM	0.238	-1.500	9.05	-10.00	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-3.18	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.69

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	0.145	1.000	-0.0864	0	[1 - 100]
returnOnEquityTTM	0.841	2.50	4.71	2.65	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.285	2.00	-0.428	-1.285	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.281	2.00	-0.427	-0.854	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.00777	1.500	-3.39	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				0.0625

PolarityTE Inc

PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.